HART Insider Trading Activity and SEC Form 4 Filings
HART insider trading summary
No open-market insider purchases or sales of Harvard Apparatus Regenerative Technology, Inc. (HART) have been reported on SEC Form 4 in the past 12 months.
Latest HART insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 17, 2015 | Saverio LaFrancesca | Chief Medical Officer | Sell | $5K (2,393 @ $1.93) |
| Dec 17, 2015 | Saverio LaFrancesca | Chief Medical Officer | Buy | $5K (2,393 @ $2.01) |
| Dec 1, 2015 | John F Kennedy | Director | Buy | $27K (9,000 @ $2.95) |
| Dec 1, 2015 | Saverio LaFrancesca | Chief Medical Officer | Buy | $30K (10,000 @ $3.01) |
| Nov 19, 2015 | James Joseph McGorry | President and CEO | Buy | $18K (10,000 @ $1.79) |
| Nov 19, 2015 | Thomas McNaughton | Chief Financial Officer | Buy | $17K (10,000 @ $1.70) |
| Nov 18, 2015 | Thomas McNaughton | Chief Financial Officer | Buy | $16K (10,000 @ $1.56) |
| Nov 17, 2015 | Thomas McNaughton | Chief Financial Officer | Buy | $20K (15,000 @ $1.32) |
| Nov 17, 2015 | David Green | Director | Buy | $34K (25,000 @ $1.34) |
| Sep 18, 2015 | Saverio LaFrancesca | Chief Medical Officer | Buy | $6K (4,500 @ $1.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.